IL67697A - 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL67697A
IL67697A IL67697A IL6769783A IL67697A IL 67697 A IL67697 A IL 67697A IL 67697 A IL67697 A IL 67697A IL 6769783 A IL6769783 A IL 6769783A IL 67697 A IL67697 A IL 67697A
Authority
IL
Israel
Prior art keywords
triazolo
preparation
pharmaceutical compositions
compositions containing
substituted
Prior art date
Application number
IL67697A
Other languages
English (en)
Other versions
IL67697A0 (en
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL67697A0 publication Critical patent/IL67697A0/xx
Publication of IL67697A publication Critical patent/IL67697A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL67697A 1982-01-18 1983-01-17 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them IL67697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18

Publications (2)

Publication Number Publication Date
IL67697A0 IL67697A0 (en) 1983-05-15
IL67697A true IL67697A (en) 1990-02-09

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67697A IL67697A (en) 1982-01-18 1983-01-17 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4788186A (de)
EP (1) EP0085840B1 (de)
JP (1) JPS58124786A (de)
KR (1) KR890000184B1 (de)
AT (1) ATE22562T1 (de)
AU (1) AU564026B2 (de)
CA (1) CA1214168A (de)
DE (1) DE3366494D1 (de)
DK (1) DK163145C (de)
ES (1) ES8601995A1 (de)
FI (1) FI81350C (de)
GR (1) GR78442B (de)
HU (1) HU193033B (de)
IE (1) IE55032B1 (de)
IL (1) IL67697A (de)
NO (1) NO161674C (de)
NZ (1) NZ203021A (de)
PH (1) PH21834A (de)
PT (1) PT76107A (de)
ZA (1) ZA83224B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
EP0915877A1 (de) * 1996-07-25 1999-05-19 MERCK SHARP & DOHME LTD. Substituierte triazolo-pyridazinderivate als inverse agonisten des gaba-a alpha-5 rezeptor subtyps
EA002436B1 (ru) * 1996-07-25 2002-04-25 Мерк Шарп Энд Домэ Лимитед Замещенные производные триазоло-пиридазина в качестве лигандов рецепторов гамк
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
WO1999036423A1 (en) * 1998-01-14 1999-07-22 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
US6579875B1 (en) * 1998-01-21 2003-06-17 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
HUP0100647A3 (en) * 1998-02-25 2003-03-28 Merck Sharp & Dohme Ltd Hoddes Substituted 1,2,4-triazolo[3,4-a]pyridazine and its pharmaceutical use
BR9908155A (pt) 1998-02-25 2000-10-31 Merck Sharp & Dohme Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
AU1816900A (en) 1998-11-12 2000-05-29 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
WO2002083064A2 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. A method of treating cancer
EP1496981A2 (de) * 2002-04-08 2005-01-19 Merck & Co., Inc. Verfahren zur behandlung von krebs
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
CA2578368C (en) * 2004-09-02 2013-07-02 Altana Pharma Ag Triazolophthalazines
BRPI0606379A2 (pt) * 2005-01-05 2009-06-23 Nycomed Gmbh triazolftalazinas
JP5130053B2 (ja) * 2005-01-05 2013-01-30 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
CN102791715B (zh) 2009-12-31 2016-04-27 卡洛斯三世国家癌症研究中心基金会 用作激酶抑制剂的三环化合物
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (de) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azoloverbindungen zur behandlung von fibrotischen erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (de) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
IE55032B1 (en) 1990-05-09
ES531458A0 (es) 1985-11-01
NO161674B (no) 1989-06-05
KR840003254A (ko) 1984-08-20
FI81350B (fi) 1990-06-29
FI830100L (fi) 1983-07-19
PT76107A (en) 1983-02-01
FI81350C (fi) 1990-10-10
DK17983A (da) 1983-07-19
DK17983D0 (da) 1983-01-18
JPS58124786A (ja) 1983-07-25
CA1214168A (en) 1986-11-18
PH21834A (en) 1988-03-17
US4788186A (en) 1988-11-29
AU564026B2 (en) 1987-07-30
JPH048428B2 (de) 1992-02-17
NO161674C (no) 1989-09-13
ES8601995A1 (es) 1985-11-01
DK163145C (da) 1992-06-22
KR890000184B1 (ko) 1989-03-09
ZA83224B (en) 1983-10-26
FI830100A0 (fi) 1983-01-12
IL67697A0 (en) 1983-05-15
ATE22562T1 (de) 1986-10-15
DK163145B (da) 1992-01-27
DE3366494D1 (de) 1986-11-06
AU1055083A (en) 1983-07-28
GR78442B (de) 1984-09-27
NZ203021A (en) 1986-05-09
EP0085840B1 (de) 1986-10-01
EP0085840A1 (de) 1983-08-17
HU193033B (en) 1987-08-28
NO830110L (no) 1983-07-19
IE830082L (en) 1983-07-18

Similar Documents

Publication Publication Date Title
IL67697A0 (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
DE3361803D1 (en) Process for the preparation of (2,2)-paracyclophane
IL70520A0 (en) Substituted phenyl sulfonyloxybenzimidazole-carbamates,process for their preparation and pharmaceutical compositions containing the same
IL68680A (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3378208D1 (en) Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds
ZA83772B (en) Substituted thienobenzodiazepinones,processes for the preparations thereof and pharmaceutical compositions containing these compounds
PT79389A (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
PT76110A (en) Process for the preparation of 3,3-dialkyl indoline and 3,3-alkylene-indoline derivatives and of pharmaceutical compositions containing them
DE3368933D1 (en) Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
IL69107A0 (en) Eburnane-oxime derivatives,process for their preparation and pharmaceutical compositions containing these compounds
DE3377217D1 (en) Process for the preparation of monobenzoylated 1,4-diaminoanthraquinones
IL65491A (en) 4-oxo-pgi2 derivatives,process for the preparation thereof and pharmaceutical compositions containing them
GB8314158D0 (en) Process for the preparation of 1,1-bisphenyl-2-haloalkan-1-ols
SG88994G (en) Process for the preparation of anti-oxidant compositions.
IL69106A0 (en) E-homo-eburnane derivatives,process for their preparation and pharmaceutical compositions containing these compounds